NPCI revises Retrieval Reference Number in UPI to avoid duplicates; PSPs and Banks to implement revised RRN and remove validation of ‘YDDD’ by 31st May, 2024. by Lexplosion Solution | Apr 24, 2024 | Central, OPS, UPIThe National Payments Corporation of India (“NPCI”) has issued an addendum to a previously issued... Read More
Public comments invited till 25th April, 2024 on draft of revised guidance for industry to align with the New Drugs and Clinical Trials (NDCT) Rules, 2019 and Sugam application process (Version 1.2) by Lexplosion Solution | Apr 19, 2024 | Central, OPS, PharmaceuticalsWith a view to align the submission procedure of clinical trial application (as prescribed under... Read More
FSSAI issues advisory to FBOs for enclosing documents as proof of premises when operating from shared workspaces by Lexplosion Solution | Apr 19, 2024 | Central, Food Industry, OPSThe Food Safety and Standards Authority of India (“FSSAI”) has in an advisory clarified the... Read More
NPCI introduces new features for Credit Accounts: introduces UPI-integrated EMI facility and UPI Autopay for Credit card bill settlements; implementation of enhancements mandated for UPI members by 31st May, 2024 by Lexplosion Solution | Apr 8, 2024 | Central, OPS, UPI MembersThe National Payments Corporation of India (“NPCI”) has introduced the following new features for... Read More
Health Ministry sets 31st December, 2024 as implementation date for Jan Vishwas Act amendments to Drugs and Cosmetics Act, 1940; drug manufacturers may be subject to increased fines for utilizing government analysts’ reports in advertisements by Lexplosion Solution | Apr 4, 2024 | Central, OPS, PharmaceuticalsPursuant to the Update reported earlier on Jan Vishwas (Amendment of Provisions) Act 2023 (please... Read More